ABSTRACT
<p><b>BACKGROUND</b>To investigate the method and therapeutic efficacy of artificial liver support system (ALSS) in treatment of severe viral hepatitis.</p><p><b>METHODS</b>A total of 83 patients including 66 with severe viral hepatitis were treated with ALSS using Baxter-550 artificial kidney and Biologic-DT system.</p><p><b>RESULTS</b>The levels of mean bilirubin, ALT, AST, BUN, Cr and endotoxin was significantly decreased after the treatment. Of the 66 patients?with severe viral hepatitis, 31(47.0%) had improvement in symptoms and 35 (53.0%) died or left hospital. In the control group,50(27.6%) out of the 181 had improvement in symptoms and 131(72.4%) died or left hospital.</p><p><b>CONCLUSIONS</b>ALSS could exert certain therapeutic effects on severe viral hepatitis.</p>
Subject(s)
Adult , Female , Humans , Male , Middle Aged , Hepatitis, Viral, Human , Therapeutics , Liver, Artificial , Treatment OutcomeABSTRACT
Fifty-five cases of cirrhotic ascites complicated with primary peritonitis were treated and analysed clinically. The results showed that high fever and diarrhea were common and severe, and the positive rate of the ascitic culture, rich in B. coli, was higher in the death group, while tenderness and reboun ding pain were prominent and typical in the survival group. The total mortality was 67.27% and the survival rate was 25.45%. 32 out of the 76 cases (some of them had been treated repeatedly) of primary peritonitis were cured (42.11%). The state of restoring health in relation to the drug sensitivity, the mode of administration and the duration of therapy were fully discussed. It was believed that the combined therapy was more effective than the single one, and the duration of the two weeks' treatment seemed to be most suitable. The early diagnosis, effective therapy and prevention were the key points for a good prognosis and better survival rate.